Article info
PDFTherapeutics/Prevention
Randomised controlled trial
Interruption of all anticoagulation is non-inferior to the use of short-term parenteral bridging in patients with atrial fibrillation undergoing invasive procedures
- Correspondence to : Dr Benjamin A Steinberg, Duke University Medical Center, Duke Clinical Research Institute P.O. Box 17969, Durham, NC 27715, USA; benjamin.steinberg{at}duke.edu
Citation
Interruption of all anticoagulation is non-inferior to the use of short-term parenteral bridging in patients with atrial fibrillation undergoing invasive procedures
Publication history
- First published September 3, 2015.
Online issue publication
April 03, 2019
Article Versions
- Previous version (3 April 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/